BioSpace News Archive

Policy

Statement from the Chief Public Health Officer of Canada on February 27, 2021

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

February 27, 2021
·
6 min read
Bio NC

Bryn Pharma Announces Presentation Of Positive Clinical Results From Multi-Dose Study Of Bi-Dose Epinephrine Nasal Spray For The Treatment Of Anaphylaxis At AAAAI Virtual Annual Meeting

Findings Demonstrate Bi-Dose Nasal Spray Device Delivered Epinephrine Levels with a Release Profile Comparable to or Greater than Epinephrine Auto-Injector

February 27, 2021
·
7 min read
Drug Development

Regeneron Announces Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma

Single administration of novel antibody cocktail controlled patients’ allergic response to cat allergen, preventing early asthma reactions for the duration of the 3-month trial

February 27, 2021
·
13 min read
BioCapital

American Pharmacists Association Comment on Authorization of Janssen Vaccine: We are Ready to Continue this Work

Statement from Scott J. Knoer, MS, PharmD, FASHP, executive vice president and CEO of the American Pharmacists Association, upon the Food and Drug Administration’s decision to authorize emergency use of Janssen Biotech’s COVID-19 vaccine:.

February 27, 2021
·
1 min read
FDA

FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine

Action Advances Fight Against COVID-19, Follows Comprehensive Evaluation of Available Safety, Effectiveness and Manufacturing Quality Information by FDA Career Scientists, Input from External Experts

February 27, 2021
·
8 min read
FDA

Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use

Shipping vaccine immediately, delivering more than 20 million doses to U.S. in March, 100 million doses in first half of 2021

February 27, 2021
·
11 min read